A carregar...

Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery

The past decade has witnessed a paradigm shift in preclinical drug discovery with structure-based drug design (SBDD) making a comeback while high-throughput screening (HTS) methods have continued to generate disappointing results. There is a deficit of information between identified hits and the man...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lounnas, Valère, Ritschel, Tina, Kelder, Jan, McGuire, Ross, Bywater, Robert P., Foloppe, Nicolas
Formato: Artigo
Idioma:Inglês
Publicado em: Research Network of Computational and Structural Biotechnology (RNCSB) Organization 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3962124/
https://ncbi.nlm.nih.gov/pubmed/24688704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5936/csbj.201302011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!